E. Iseki et al., Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease, NEUROSCI L, 258(2), 1998, pp. 81-84
We investigated the hippocampal pathology in diffuse Lewy body disease (DLB
D) using alpha-synuclein immunohistochemistry. Ubiquitin-positive intrahipp
ocampal structures caused by the degeneration of terminal axons of the perf
orant pathway were observed to be alpha-synuclein immunoreactive. These alp
ha-synuclein-positive degenerative terminals contained granulo-filamentous
or vesiculo-tubular components similar to those of Lewy bodies (LB) immunoe
lectron microscopically, suggesting that alpha-synuclein may abnormally agg
regate into filamentous or membranous cytoskeletal components including neu
rofilaments and synaptic vesicles in DLBD. A 'dying back' degenerating proc
ess due to a blockage of axonal transport may explain why the degenerative
terminals and LB share similar alpha-synuclein-positive components, but the
origin cells of the perforant pathway contain only a few LB. (C) 1998 Else
vier Science Ireland Ltd. All rights reserved.